Central nervous system (CNS) injuries are a leading cause of long-term disability ... “Coupling these materials with ...

Researchers are paving the way for the design of bionic limbs that feel natural to users. They demonstrate the connection ...

E-commerce has changed how businesses operate, becoming a central nervous system. It offers consumers speed, convenience, and ...

Irritable bowel syndrome (IBS) is a common digestive disorder that affects the intestine, causing symptoms such as abdominal pain, bloating, gas, and ...

Abstract Research of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Fibromyalgia (FM), two acquired chronic illnesses affecting mainly females, has failed to ascertain their frequent ...

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company with a market capitalization of $3.06 billion, focuses on developing and commercializing innovative medicines to address unmet ...

Researchers at the Istituto Italiano di Tecnologia (Italian Institute of Technology) in Italy and Imperial College London in ...

There is growing momentum to legalize certain psychedelics — namely psilocybin. That push is well underway in Nevada.

Alliance Global Partners initiated coverage of CNS Pharmaceuticals (CNSP) with a Buy rating and $4 price target CNS is a clinical-stage ...

Oppenheimer initiated coverage of Alumis (ALMS) with an Outperform rating and $32 price target The company is focused on delivering ...